SOURCE: Robert Bosch Healthcare

Robert Bosch Healthcare, Telehealth

December 16, 2010 12:30 ET

Robert Bosch Healthcare Withdraws From Northern Ireland Tender Process

-- Decision Based on Evolving Service Delivery's and Budgetary Requirements

-- Company Continues to Pursue Other Opportunities in the UK and Other Countries

DENHAM, ENGLAND--(Marketwire - December 16, 2010) - Robert Bosch Healthcare has elected to withdraw from the tender process, conducted under the auspices of the European Center for Connected Health (ECCH), for selection of a vendor to supply telehealth technology for a project in Northern Ireland. The tender process is intended to facilitate an initial deployment of telehealth-based care-management to support individuals in Northern Ireland who struggle with severe chronic conditions, both to improve quality of care and reduce costs.

Bosch Healthcare's decision is based on the evolving service delivery and budgetary requirements of the proposed project. Bosch Healthcare was one out of three finalists in the process.

Bosch Healthcare is continuing to pursue other opportunities in the developing United Kingdom market for telehealth technology and the healthcare interventions that the technology supports. Bosch Healthcare recently initiated its first UK project in conjunction with the Barnsley Primary Care Trust, with an initial deployment of telehealth-based services to 150 individuals diagnosed with congestive heart failure (CHF). Bosch Healthcare's UK operations are based in Denham, England.

Robert Bosch Healthcare Inc. is a leading provider of innovative telehealth systems. Bosch's product spectrum ranges from patient terminals to comprehensive evaluation software allowing healthcare professionals to efficiently evaluate the data coming from the patient terminals and other connected devices. Bosch Telehealth strives to improve diagnosis and treatment through systematic patient monitoring and involvement. The result is that health professionals are able to provide a higher quality of care for patients with chronic conditions, patients lead happier and healthier lives, and the cost of healthcare is reduced for funders. Robert Bosch Healthcare, Inc. is a fully-owned subsidiary of the Bosch Group. For more information, go to

The Bosch Group is a leading global supplier of technology and services. In the areas of automotive and industrial technology, consumer goods, and building technology, some 275,000 associates generated sales of 38.2 billion euros (roughly $53 billion) in fiscal 2009. The Bosch Group comprises Robert Bosch GmbH and its more than 300 subsidiaries and regional companies in over 60 countries. If its sales and service partners are included, then Bosch is represented in roughly 150 countries. This worldwide development, manufacturing, and sales network are the foundation for growth. Each year, Bosch spends more than 3.5 billion euros ($4.8 billion) for research and development, and applies for some 3,800 patents worldwide. With all its products and services, Bosch enhances the quality of life by providing solutions which are both innovative and beneficial.

The company was set up in Stuttgart in 1886 by Robert Bosch (1861-1942) as "Workshop for Precision Mechanics and Electrical Engineering." The special ownership structure of Robert Bosch GmbH guarantees the entrepreneurial freedom of the Bosch Group, making it possible for the company to plan over the long term and to undertake significant up-front investments in the safeguarding of its future. Ninety-two percent of the share capital of Robert Bosch GmbH is held by Robert Bosch Stiftung GmbH, a charitable foundation. The majority of voting rights are held by Robert Bosch Industrietreuhand KG, an industrial trust. The entrepreneurial ownership functions are carried out by the trust. The remaining shares are held by the Bosch family and by Robert Bosch GmbH. Additional information can be accessed at

Contact Information